Evaluation of a Cytokine Combination Including Thrombopoietin for Improved Transduction of a Retroviral Gene into G‐CSF‐Mobilized CD34 + Human Blood Cells
- 1 September 1997
- journal article
- research article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 15 (5), 347-352
- https://doi.org/10.1002/stem.150347
Abstract
We examined cell culture conditions with various combinations of cytokines including thrombopoietin (TPO) to obtain the most efficient transduction of recombinant retrovirus vectors into G‐CSF‐mobilized blood CD34+ cells which were obtained from children and purified with an Isolex 50 system (Baxter; Deerfield, IL). Three different 4‐day culture conditions for the stimulation of CD34+ cells were compared in terms of a cell‐cycle analysis by fluorometry and gene transduction efficiency as determined by resistance to G418 and NeoR polymerase chain reaction (PCR) for individual colony‐forming unit‐granulocyte/macrophage (CFU‐GM) grown in a methylcellulose culture system. The cytokines tested were: A) interleukin (IL)‐6 + stem cell factor (SCF); B) IL‐3 + IL‐6 + SCF, and C) IL‐3 + IL‐6 + SCF + TPO. Without a cell culture, the percentage of CD34+ cells in the cell cycle (the percentage of cells in phases S and G2/M) was 4.6%. After a four‐day culture (n = 5), this value increased with the addition of IL‐3 (22%) or IL‐3 + TPO (27%, p < 0.05) as compared to that with the baseline cocktail of IL‐6 + SCF (15%). The cell number uniformly increased approximately 10‐fold in each culture condition. The average efficiency of gene transfer into incubated CD34+ cells with the corresponding combinations of cytokines was, respectively, 57%, 47%, and 30% for G418‐screened CFU‐GM and 72%, 68%, and 51% for polymerase chain reaction‐positive CFU‐GM. A statistically significant difference (p < 0.01) was found for G418/CFU‐GM with IL‐3 + IL‐6 + SCF (57%) versus IL‐3 + IL‐6 + SCF + TPO (30%). Hence, it is likely that the increased cell proliferation produced by the addition of TPO was not necessarily translated into an increased rate of retroviral‐mediated gene transduction, possibly because TPO preferentially induced the differentiation of stem cells into mature progenitors in these culture systems.Keywords
This publication has 10 references indexed in Scilit:
- Retroviral transduction of human progenitor cells: use of granulocyte colony-stimulating factor plus stem cell factor to mobilize progenitor cells in vivo and stimulation by Flt3/Flk-2 ligand in vitroBlood, 1996
- Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor.Proceedings of the National Academy of Sciences, 1996
- Thrombopoietin Suppresses Apoptosis and Behaves as a Survival Factor for the Human Growth Factor‐Dependent Cell Line, M07eThe International Journal of Cell Cloning, 1996
- Gene Therapy — Promise, Pitfalls, and PrognosisNew England Journal of Medicine, 1995
- The current status of gene therapy using hematopoietic stem cellsCurrent Opinion in Pediatrics, 1995
- High efficiency retroviral mediated gene transduction into single isolated immature and replatable CD34(3+) hematopoietic stem/progenitor cells from human umbilical cord blood.The Journal of Experimental Medicine, 1993
- Immunomagnetic Separation of CD34+Cells from Human Bone Marrow, Cord Blood, and Mobilized Peripheral BloodJournal of Hematotherapy, 1993
- Comparison of the Effects of Growth Factors on Retroviral Vector-Mediated Gene Transfer and the Proliferative Status of Human Hematopoietic Progenitor CellsHuman Gene Therapy, 1990
- Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection.Molecular and Cellular Biology, 1990
- Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells.Proceedings of the National Academy of Sciences, 1989